Mona Ashiya sold $2.8M of IRON
director at Disc Medicine, Inc.. 52,429 shares at an average of $54.02, traded Mar 19, 2025, filed Mar 21, 2025.
Score components
- +15RoleDirector
- +25Trade size$2.8M at market
- +5Share of holdings soldSold 10% of holdings
- +8Cluster2 insiders selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0000947871-25-000334, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Mar 19, 2025 | SOpen-market sale Common Stockindirect: See Footnotes | -13,517 | $54.02 | $730k | 488,617 | Mar 21, 2025 |
| Mar 19, 2025 | SOpen-market sale Common Stockindirect: See Footnotes | -20,911 | $54.02 | $1.1M | 755,933 | Mar 21, 2025 |
| Mar 19, 2025 | SOpen-market sale Common Stockindirect: See Footnotes | -5,228 | $54.02 | $282k | 188,981 | Mar 21, 2025 |
| Mar 20, 2025 | SOpen-market sale Common Stockindirect: See Footnotes | -941 | $54.01 | $51k | 487,676 | Mar 21, 2025 |
| Mar 20, 2025 | SOpen-market sale Common Stockindirect: See Footnotes | -1,457 | $54.01 | $79k | 754,476 | Mar 21, 2025 |
| Mar 20, 2025 | SOpen-market sale Common Stockindirect: See Footnotes | -364 | $54.01 | $20k | 188,617 | Mar 21, 2025 |
| Mar 21, 2025 | SOpen-market sale Common Stockindirect: See Footnotes | -3,412 | $54.00 | $184k | 484,264 | Mar 21, 2025 |
| Mar 21, 2025 | SOpen-market sale Common Stockindirect: See Footnotes | -5,279 | $54.00 | $285k | 749,197 | Mar 21, 2025 |
| Mar 21, 2025 | SOpen-market sale Common Stockindirect: See Footnotes | -1,320 | $54.00 | $71k | 187,297 | Mar 21, 2025 |
Related signals
Other insiders at Disc Medicine, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 45Moderate | IRONsell Disc Medicine, Inc. | Kevin Bitterman director | $1.9M 27,136 shares | -100% | |
| 6Weak | Disc Medicine, Inc. | Kevin Bitterman director | $135k 1,689 shares | -1% | |
| 25Weak | Disc Medicine, Inc. | Kevin Bitterman director | $4.4M 54,496 shares | -16% | |
| 6Weak | Disc Medicine, Inc. | Kevin Bitterman director | $140k 2,287 shares | -0% | |
| 20Weak | Disc Medicine, Inc. | Kevin Bitterman director | $2.0M 32,174 shares | -5% | |
| 0Weak | Disc Medicine, Inc. | Kevin Bitterman director | $24k 395 shares | -0% | |
| 21Weak | Disc Medicine, Inc. | Kevin Bitterman director | $518k 8,492 shares | -1% | |
| 55Moderate | Disc Medicine, Inc. | Kevin Bitterman director | $2.6M 42,870 shares | -6% | |
| 36Weak | Disc Medicine, Inc. | Kevin Bitterman director | $41k 664 shares | -0% | |
| 27Weak | Disc Medicine, Inc. | Jean M. Franchi Chief Financial Officer | $120k 2,031 shares | -3% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.